Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411328 (US10385031, Compound 034 | US10774056, Compound 03...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411384 (US10385031, Compound 090 | US10774056, Compound 09...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411330 (US10385031, Compound 036 | US10774056, Compound 03...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411331 (US10385031, Compound 037 | US10774056, Compound 03...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411332 (US10385031, Compound 038 | US10774056, Compound 03...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411333 (US10385031, Compound 039 | US10774056, Compound 03...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM411333 (US10385031, Compound 039 | US10774056, Compound 03...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411334 (US10385031, Compound 040 | US10774056, Compound 04...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM411334 (US10385031, Compound 040 | US10774056, Compound 04...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411335 (US10385031, Compound 041 | US10774056, Compound 04...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411336 (US10385031, Compound 042 | US10774056, Compound 04...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411337 (US10385031, Compound 043 | US10774056, Compound 04...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411340 (US10385031, Compound 046 | US10774056, Compound 04...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411341 (US10385031, Compound 047 | US10385031, Compound 04...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411342 (US10385031, Compound 048 | US10774056, Compound 04...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM461284 (US10774056, Compound 049 | US11542242, Compound 04...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411344 (US10385031, Compound 050 | US10774056, Compound 05...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411345 (US10385031, Compound 051 | US10774056, Compound 05...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM411345 (US10385031, Compound 051 | US10774056, Compound 05...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411346 (US10385031, Compound 052 | US10774056, Compound 05...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411347 (US10385031, Compound 053 | US10774056, Compound 05...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM411347 (US10385031, Compound 053 | US10774056, Compound 05...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411348 (US10385031, Compound 054 | US10774056, Compound 05...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411358 (US10385031, Compound 064 | US10774056, Compound 06...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411359 (US10385031, Compound 065 | US10774056, Compound 06...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411360 (US10385031, Compound 066 | US10774056, Compound 06...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411361 (US10385031, Compound 067 | US10774056, Compound 06...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411362 (US10385031, Compound 068 | US10774056, Compound 06...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411364 (US10385031, Compound 070 | US10774056, Compound 07...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411365 (US10385031, Compound 071 | US10774056, Compound 07...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411368 (US10385031, Compound 074 | US10774056, Compound 07...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411369 (US10385031, Compound 075 | US10774056, Compound 07...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411370 (US10385031, Compound 076 | US10774056, Compound 07...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411373 (US10385031, Compound 079 | US10774056, Compound 07...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411374 (US10385031, Compound 080 | US10774056, Compound 08...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM411374 (US10385031, Compound 080 | US10774056, Compound 08...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411376 (US10385031, Compound 082 | US10774056, Compound 08...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411377 (US10385031, Compound 083 | US10774056, Compound 08...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411379 (US10385031, Compound 085 | US10774056, Compound 08...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411380 (US10385031, Compound 086 | US10774056, Compound 08...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM411380 (US10385031, Compound 086 | US10774056, Compound 08...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411381 (US10385031, Compound 087 | US10774056, Compound 08...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411382 (US10385031, Compound 088 | US10774056, Compound 08...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 1 (Homo sapiens (Human)) | BDBM411329 (US10385031, Compound 035 | US10774056, Compound 03...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were... | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM411328 (US10385031, Compound 034 | US10774056, Compound 03...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 255 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 3 (Homo sapiens (Human)) | BDBM411328 (US10385031, Compound 034 | US10774056, Compound 03...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 255 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM411329 (US10385031, Compound 035 | US10774056, Compound 03...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 255 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 3 (Homo sapiens (Human)) | BDBM411329 (US10385031, Compound 035 | US10774056, Compound 03...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 255 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 2 (Homo sapiens (Human)) | BDBM411330 (US10385031, Compound 036 | US10774056, Compound 03...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 255 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Histone deacetylase 3 (Homo sapiens (Human)) | BDBM411330 (US10385031, Compound 036 | US10774056, Compound 03...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 255 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, INC. US Patent | US Patent US10774056 (2020) BindingDB Entry DOI: 10.7270/Q25D8VXS | ||||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 197 total ) | Next | Last >> |